- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03001752
Immediate Implants Inserted Through Open Flap, Open Flap and Bone Grafting and Flapless Techniques (ETPEI-RCT)
Evaluation of Morphological and Dimensional Alveolar Bone Changes Around Post-extraction Implants in an Open Flap, Open Flap and Grafting and Flapless Technique. A Clinical Randomized Controlled Study
Study Overview
Status
Conditions
Detailed Description
Background and Objectives A recent systematic review investigating dimensional alveolar bone changes after insertion of post-extraction implants reported that there is a lack of randomized controlled trials that would serve as a scientific base for building clinical guidelines on alveolar site treatment after insertion of post-extraction implants. Different studies suggest that insertion of post-extraction implants should be performed after fully elevating a flap and inserting bone graft in the residual space between the implant surface and the alveolar socket. Other investigations report insignificant differences between open flap and flapless approaches, whereas the insertion of bone grafts remains controversial.
The present study is a three-armed randomized clinical controlled trial conducted with the following objectives:
- Evaluation of morphological and alveolar bone level differences (marginal bone loss) on post-extraction implants inserted with the following techniques: 1) open flap surgery alone; 2) open flap surgery and bone grafting; 3) flapless.
- Estimation of effectiveness of the three surgical techniques through measurement of secondary outcomes such as intra-operatory and post-operatory complications, pain and discomfort, time and costs.
Materials and Methods
- This is a three-armed randomized controlled clinical trial where each arm will belong to one of the treatments: 1) open flap surgery alone; 2) open flap surgery and bone grafting; 3) flapless.
- The randomizing sequence will be generated from a computer program (STATA 13) by a statistician who will also conduct blind statistical analysis of results.
- All patients will be recruited prior to trial commencement. They will be extensively informed regarding the intervention and will sign a treatment consent.
- Patients will be recruited according to the following inclusion criteria: absence of any systemic disease that might compromise implant integration or wound healing, appropriate periodontal health (measured through periodontal indexes), presence of premolars with indications of extractions, presence of adjacent teeth, absence of fenestrations, presence of vestibular alveolar wall with a minimum of 0.5mm of thickness. Patients who have undergone CT scanning in the past 5 years and heavy smokers (more than 20 cigarettes per day) will not be included in the study.
- Calculation of sample size has already been performed by an experienced statistician, accounting for a minimal predicted difference between groups of 1mm (SD 0.75mm) of marginal bone loss, alpha error of 0.05 and 90% of power. Based on these calculations, a total of 45 patients will be included in the study.
- Interventions will be performed in accordance with ethical standards as suggested by the Helsinki Declaration (1975). Approval of Ethical Committee of the University of Bari has already been obtained (reg.nr. 4987).
- All surgical interventions will be performed by the same experienced surgeon who will be informed of the type of intervention after tooth extraction (allocation concealment through dark sealed envelopes).
- The primary outcome is marginal bone loss (MBL) and alveolar bone dimensional changes measured through CT Cone Beam performed immediately after implant insertion and 6 months after. Secondary outcomes are intra-and post-operative complications, pain and discomfort, time and costs.
- Outcomes will be measured by another clinician blinded in terms of treatment allocation.
- Statistical analysis will be performed by an independent statistician. Statistical tests will include: One-way Anova, Bonferroni tests and several linear and logistic regressions in order to estimate potential predictive variables. Statistical significance will be set at .05.
- Interruption of study will be considered in the following situations: 1.preliminary observation of highly significant difference between techniques indicating one technique highly superior; 2. big number of lost to follow-up (bigger than that considered during sample size calculation)
- Patients will be excluded from the study in the following cases: missing follow-up hygiene controls at 1 and 3 months post-intervention, missing 6 months follow-up control, poor cooperation in terms of domestic oral hygiene (periodontal indexes measured), income of systemic or local diseases that might compromise outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- absence of any systemic disease that might compromise implant integration or wound healing
- appropriate periodontal health (measured through periodontal indexes)
- presence of premolars with indications of extractions, presence of adjacent teeth
- absence of fenestrations
- presence of vestibular alveolar wall with a minimum of 0.5mm of thickness
Exclusion Criteria:
- patients who have undergone CT scanning in the past 5 years
- heavy smokers (more than 20 cigarettes per day)
- patients not showing up at 1 and 3 months hygiene sessions
- patients not showing up at 6 months follow-up
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Open flap immediate implant
Open flap immediate implant insertion, without bone grafting
|
Post-extraction implants will be inserted through open flap, without bone grafting
Other Names:
|
Active Comparator: Open flap immediate implant and bone grafting
Open flap immediate implant insertion and bone grafting
|
Post-extraction implants will be inserted through open flap, adding bone grafting
Other Names:
|
Active Comparator: Flapless immediate implant
Immediate implant insertion without opening flap of inserting bone grafting
|
Post-extraction implants will be inserted without elevating flap or inserting bone grafting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Marginal Bone Loss measured through CT Cone Beam
Time Frame: 6 months
|
Difference of marginal bone level measured immediately after treatment and 6 months after on two repeated (immediately after and 6 months after implant insertion) CT Cone Beam
|
6 months
|
Alveolar Bone Dimensional Reduction assessed through CT Cone Beam
Time Frame: 6 months
|
Three-dimensional Alveolar Bone Reduction (horizontal and vertical) will be measured on two repeated (immediately after and 6 months after implant insertion) on CT Cone Beam, having as reference points the implant platform and the implant apex.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain and Discomfort measured through questionaire
Time Frame: 1 Week
|
Pain and discomfort experienced by the patient after the surgery, measured through a VAS scale on a questionaire
|
1 Week
|
Intra-operatory or post-operatory complications assessed through intra-operatory observation and post-intervention check-ups.
Time Frame: 6 months
|
Intra-operatory or post-operatory intervention-related adverse events such as excessive bleeding, swallowing, hematoma will be recorded for each patient.
|
6 months
|
Time needed to perform surgical intervention
Time Frame: 1-2 hours
|
Time needed to perform surgical intervention (immediately after tooth extraction until finishing of surgical procedure) will be recorded for each intervention.
|
1-2 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Lee CT, Chiu TS, Chuang SK, Tarnow D, Stoupel J. Alterations of the bone dimension following immediate implant placement into extraction socket: systematic review and meta-analysis. J Clin Periodontol. 2014 Sep;41(9):914-26. doi: 10.1111/jcpe.12276. Epub 2014 Jul 23.
- Tarnow DP, Chu SJ. Human histologic verification of osseointegration of an immediate implant placed into a fresh extraction socket with excessive gap distance without primary flap closure, graft, or membrane: a case report. Int J Periodontics Restorative Dent. 2011 Sep-Oct;31(5):515-21.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4987
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Isolated Premolar Edentulous Site
-
Francesco GianfredaCompletedImplant Site Reaction | Edentulous Jaw | Full Digital WorkflowItaly
-
UNICANCERSeagen Inc.; ARCAGY/ GINECO GROUPRecruitingMetastatic Breast Cancer With a Isolated Brain ProgressionFrance
-
First Affiliated Hospital of Zhejiang UniversityRecruitingColorectal Cancer | Synchronous Isolated Para-aortic Lymph Node MetastasisChina
-
Barts & The London NHS TrustRecruitingAcromegaly | Gigantism | Familial Isolated Pituitary Adenoma | FIPA | Pituitary Adenoma Predisposition | PAPUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
UK Kidney AssociationRecruitingVasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditionsUnited Kingdom
-
National Cancer Institute (NCI)CompletedHIV Infection | Clear Cell Renal Cell Carcinoma | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Burkitt Lymphoma | Secondary... and other conditionsUnited States
Clinical Trials on Open flap immediate implant
-
Columbia UniversityCompletedGingival Recession | Bone Loss, Alveolar
-
Cairo UniversityCompletedAlveolar Socket PreservationEgypt
-
The Royal College of Surgeons of EdinburghRecruitingAlveolar Bone LossEgypt, Germany
-
Federal University of Rio Grande do SulRecruiting
-
Ain Shams UniversityNot yet recruitingPeriodontal Diseases
-
Scil Technology GmbHFGK Clinical Research GmbHUnknownPeriodontal Bone Loss | Alveolar Bone LossHungary
-
University of OsloWithdrawnPeriodontal Diseases | Furcation DefectsNorway
-
University of OsloWithdrawnPeriodontal Diseases | Furcation DefectsNorway
-
Cairo UniversityCompleted
-
Hams Hamed AbdelrahmanCompletedDental Implants | Edentulous Alveolar RidgeEgypt